Lidia Parada Pena
Family · Port Charlotte, FLNPI 1770231383
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,579 of the $1,762 with a category attached, or 89.6%. It is spread thinly across 29 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations.
Across 72 payments — averaging $24.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$188
- Takeda Pharmaceuticals U.S.A., Inc.$180
- Merck$131
- Lilly USA, LLC$128
- Novartis$123
- E.r. Squibb & Sons, L.L.C.$104
- plus $909 from 23 others
What the payments were for
- Food & beverage$1,57990%
- Education$18310%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 5 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $180 |
| Merck | 5 | $131 |
| Lilly USA, LLC | 3 | $128 |
| Novartis | 6 | $123 |
| E.r. Squibb & Sons, L.L.C. | 5 | $104 |
| AstraZeneca(2 entities) | 4 | $87 |
| Pfizer | 3 | $82 |
| Gilead(2 entities) | 3 | $73 |
| Sobi, Inc | 3 | $72 |
| Astellas Pharma US Inc | 4 | $66 |
| Daiichi Sankyo Inc. | 2 | $59 |
| Legend Biotech USA Inc. | 2 | $52 |
| Beone Medicines USA, Inc. | 2 | $51 |
| Puma Biotechnology, Inc. | 2 | $36 |
| AVEO Pharmaceuticals, Inc. | 2 | $36 |
| Genentech USA, Inc. | 2 | $32 |
| Eisai Inc. | 2 | $31 |
| Stemline Therapeutics Inc. | 1 | $28 |
| Bayer | 1 | $28 |
| Iovance Biotherapeutics, Inc. | 1 | $24 |
| Exelixis Inc. | 1 | $23 |
| Geron Corporation | 1 | $20 |
| Genmab U.S., Inc. | 1 | $20 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| GSK | 1 | $19 |
| Array Biopharma Inc | 1 | $19 |
| Johnson & Johnson | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
How this compares
$1,762 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Other family in Port Charlotte
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.